PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Confers Product Differentiation Excellence Award on Frutarom for Origanox™ - Origanox™ is a high-performance, multi-beneficial, cost-effective natural plant extract
Frost & Sullivan Confers Product Differentiation Excellence Award on Frutarom for Origanox™


NewswireToday - /newswire/ - London, United Kingdom, 2013/03/25 - Origanox™ is a high-performance, multi-beneficial, cost-effective natural plant extract.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Based on its recent analysis of the natural antioxidants market, Frost & Sullivan recognises Frutarom Ltd with the 2013 European Product Differentiation Excellence Award. The company is commended for its outstanding natural plant extract - Origanox™.

"Origanox™ is a novel ingredient manufactured from a unique set of raw materials - oregano, lemon balm and or herb spices - that serve as natural plant extract intended to maintain the quality during shelf-life of food products," noted Frost & Sullivan Research Analyst Ashwin Raj Ravinder. "It offers excellent stability and solubility, backed by strong science and innovative technology. Origanox™ represents a high-performance, cost-effective solution compared to other natural antioxidants available in the market."

One of the key challenges faced by other naturally derived antioxidants like natural tocopherols is raw material supply shortages. In contrast, Frutarom has unrestricted access to the raw materials on which Origanox™ is based, thereby assuring steady long-term supply to customers.

Origanox™ scores on the price-performance ratio; it is priced lower than tocopherols and provides high functionality. And, while prices are comparable with rosemary extracts, Origanox™ still gains in terms of its superior organoleptic properties and its milder flavour.

"Origanox™ supports reduced dosage levels, wider application coverage, enhanced solubility and the ability to perform under challenging conditions, like high temperature," remarked Ravinder. "Value-added benefits include the masking of odours, retarding the deterioration of colours, improving overall flavour, cost-efficiency, patented manufacturing process, cutting-edge technology, tailor made

Frutarom's unique and patented solvent-free technology, is a cutting-edge technology that ensures Origanox™'s all-natural properties and gives it the ‘clean label' tag. The solution is certified organic by the U.S. FDA.

The multiple formats and dosage offered by Frutarom are designed to suit varied customer needs. The solution is available in both oil soluble and water soluble formats, according to the end applications where it is incorporated.

"Its superior carry through properties that guide it in withstanding high temperature make it the perfect choice for frying and baking applications," said Ravinder. "Its ability to dissolve quickly in cold water makes it the ultimate choice for beverage and meat manufacturers, and is extremely efficient in cold water.

Additionally, Origanox™ has a mild taste in the final consumer product, unlike other natural and synthetic antioxidants in the market that often leave a trail of strong odour or flavour. Customers also have the option of choosing a mild flavoured grade that can be used for specific applications.

"Frutarom provides technical assistance to all its customers; technical labs perform free sample analysis, while providing guidance at all levels of product development," concluded Ravinder. "Prescriptive services help customers identify the dosage levels of Origanox™ that best suit their specific requirements. Furthermore, Origanox™ does not create any additional investments or shifting of cost to customers."

Frost & Sullivan presents this award to the company that has demonstrated excellence in developing product(s) with unique features/functionality, superior quality/complexity and that support customisation. The ability to effectively target market needs and the brand perception of the uniqueness of the product(s) also underlie the receipt of this award.

Frost & Sullivan Best Practices awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Frutarom Ltd
Established in 1933, Frutarom is a rapidly growing global flavor and fine ingredients company and is numbered among the ten leading companies in the world, in the field of flavors & fragrances.

Frutarom creates, develops, manufactures and markets an extensive variety of high quality flavors and fine ingredients for customers in the food, beverage, functional food, flavor, fragrance, pharmaceutical, nutraceutical, and cosmetic industries. Frutarom markets and sells over 30,000 products to more than 14,000 customers in 140 countries, has 31 R&D labs and 50 sales and marketing offices throughout the world and operates 20 production facilities in Europe, North America, Israel and Asia. Frutarom employs 2000 employees worldwide.

About Frost & Sullivan
Frost & Sullivan (, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Frost & Sullivan Confers Product Differentiation Excellence Award on Frutarom for Origanox™

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Emily Bailey 
+44(0)20 7915 7869 emily.bailey[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Frost & Sullivan / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  NAKIVO, Inc.

Visit  RightITnow Ltd

  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (